Edmonton, Alberta, Canada
November 22, 2007
Innovotech (TSX
VENTURE:IOT) has filed for regulatory approval with the US
Environmental Protection Agency for AgressTM, its novel seed
treatment for diseases of soy and bean crops. "Agress™ is a
breakthrough seed treatment as it is the only product effective
against both fungal and bacterial crop diseases. In addition, it
has an outstanding environmental safety profile and is
cost-competitive with current products" says Wolfgang Muhs, CEO
of Innovotech.
Soy and bean crops alone represent greater than $500 million in
sales potential annually for Agress™ in North and South America.
The company has initial research results indicating the efficacy
of Agress™ in treating other high value agricultural crops and
is currently pursuing these opportunities in parallel with this
regulatory filing.
Innovotech is a product development company focusing on the
development of solutions to medical, agricultural and industrial
problems caused by microbial biofilms. Biofilms are protected
communities of microorganisms which are very common and very
difficult to treat due to their inherent resistance. They have
been implicated in a host of devastating infections in
agriculture, human health and industry. No diagnostics or
antibiotics are currently approved for use in infections
involving biofilms. |
|
